Skip to content
  • Kendall Square >
    • Calendar
    • Cater Kendall
    • Getting Around
    • History + Tours
    • Map
    • Little Libraries
    • Kendall Volunteers
  • Kendall Square Association >
    • About
    • Membership
    • KSA Events
    • KSA Programs
    • Kendall GREEN
    • Strategic Initiatives
    • Government Relations
    • Board
    • Emerging Leaders
    • Team
    • KSA Blog + Media Library
  • Events & Culture
  • Transportation
  • DEI - Inclusion Drives Innovation
  • Work Now Task Force
  • Kendall Collaborations
  • About
  • Join KSA

Announcements

Biogen, placing a major bet on a once-failed treatment, is paying $1.53 billion for the commercial rights to a Sage Therapeutics’ oral depression drug, zuranolone.

Dec 01, 2020

Share

  • Share on Twitter
  • Share on Facebook
/
  • Events & Culture
  • DEI - Inclusion Drives Innovation
  • Transportation
  • Work Now
  • Kendall Collaborations
  • About
  • Membership

Kendall Square Association

510 Kendall Street
Cambridge, MA 02142

617-945-9434
hello@kendallsquare.org

Stay up to date with the latest news from Kendall Square.

Submitting...
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

© Kendall Square Association 2023

Back to Top